These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 19277041

  • 1. Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo.
    Ulasov IV, Sonabend AM, Nandi S, Khramtsov A, Han Y, Lesniak MS.
    Br J Cancer; 2009 Apr 07; 100(7):1154-64. PubMed ID: 19277041
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Rational incorporation of selenium into temozolomide elicits superior antitumor activity associated with both apoptotic and autophagic cell death.
    Cheng Y, Sk UH, Zhang Y, Ren X, Zhang L, Huber-Keener KJ, Sun YW, Liao J, Amin S, Sharma AK, Yang JM.
    PLoS One; 2012 Apr 07; 7(4):e35104. PubMed ID: 22496897
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma.
    Ulasov IV, Zhu ZB, Tyler MA, Han Y, Rivera AA, Khramtsov A, Curiel DT, Lesniak MS.
    Hum Gene Ther; 2007 Jul 07; 18(7):589-602. PubMed ID: 17630837
    [Abstract] [Full Text] [Related]

  • 6. Oncolytic adenoviral vectors which employ the survivin promoter induce glioma oncolysis via a process of beclin-dependent autophagy.
    Ulasov IV, Tyler MA, Zhu ZB, Han Y, He TC, Lesniak MS.
    Int J Oncol; 2009 Mar 07; 34(3):729-42. PubMed ID: 19212678
    [Abstract] [Full Text] [Related]

  • 7. CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma.
    Kaliberova LN, Krendelchtchikova V, Harmon DK, Stockard CR, Petersen AS, Markert JM, Gillespie GY, Grizzle WE, Buchsbaum DJ, Kaliberov SA.
    Cancer Gene Ther; 2009 Oct 07; 16(10):794-805. PubMed ID: 19363468
    [Abstract] [Full Text] [Related]

  • 8. Combined therapy of oncolytic adenovirus and temozolomide enhances lung cancer virotherapy in vitro and in vivo.
    Gomez-Gutierrez JG, Nitz J, Sharma R, Wechman SL, Riedinger E, Martinez-Jaramillo E, Sam Zhou H, McMasters KM.
    Virology; 2016 Jan 07; 487():249-59. PubMed ID: 26561948
    [Abstract] [Full Text] [Related]

  • 9. Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy.
    Lin CJ, Lee CC, Shih YL, Lin TY, Wang SH, Lin YF, Shih CM.
    Free Radic Biol Med; 2012 Jan 15; 52(2):377-91. PubMed ID: 22094224
    [Abstract] [Full Text] [Related]

  • 10. Concomitant treatment with pertussis toxin plus temozolomide increases the survival of rats bearing intracerebral RG2 glioma.
    Magaña-Maldonado R, Manoutcharian K, Hernández-Pedro NY, Rangel-López E, Pérez-De la Cruz V, Rodríguez-Balderas C, Sotelo J, Pineda B.
    J Cancer Res Clin Oncol; 2014 Feb 15; 140(2):291-301. PubMed ID: 24337403
    [Abstract] [Full Text] [Related]

  • 11. Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo.
    Tyler MA, Ulasov IV, Sonabend AM, Nandi S, Han Y, Marler S, Roth J, Lesniak MS.
    Gene Ther; 2009 Feb 15; 16(2):262-78. PubMed ID: 19078993
    [Abstract] [Full Text] [Related]

  • 12. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
    Yu Z, Xie G, Zhou G, Cheng Y, Zhang G, Yao G, Chen Y, Li Y, Zhao G.
    Cancer Lett; 2015 Oct 10; 367(1):58-68. PubMed ID: 26188279
    [Abstract] [Full Text] [Related]

  • 13. Potential application of temozolomide in mesenchymal stem cell-based TRAIL gene therapy against malignant glioma.
    Kim SM, Woo JS, Jeong CH, Ryu CH, Jang JD, Jeun SS.
    Stem Cells Transl Med; 2014 Feb 10; 3(2):172-82. PubMed ID: 24436439
    [Abstract] [Full Text] [Related]

  • 14. Enhancement of glioma radiotherapy and chemotherapy response with targeted antibody therapy against death receptor 5.
    Fiveash JB, Gillespie GY, Oliver PG, Zhou T, Belenky ML, Buchsbaum DJ.
    Int J Radiat Oncol Biol Phys; 2008 Jun 01; 71(2):507-16. PubMed ID: 18474311
    [Abstract] [Full Text] [Related]

  • 15. Local delivery of slow-releasing temozolomide microspheres inhibits intracranial xenograft glioma growth.
    Dong J, Zhou G, Tang D, Chen Y, Cui B, Dai X, Zhang J, Lan Q, Huang Q.
    J Cancer Res Clin Oncol; 2012 Dec 01; 138(12):2079-84. PubMed ID: 22825126
    [Abstract] [Full Text] [Related]

  • 16. Hispidulin Enhances Temozolomide (TMZ)-Induced Cytotoxicity against Malignant Glioma Cells In Vitro by Inhibiting Autophagy.
    Chen Z, Zhu G, Sheng C, Lei J, Song S, Zhu J.
    Comput Intell Neurosci; 2022 Dec 01; 2022():5266770. PubMed ID: 35800695
    [Abstract] [Full Text] [Related]

  • 17. Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells.
    Kanzawa T, Germano IM, Komata T, Ito H, Kondo Y, Kondo S.
    Cell Death Differ; 2004 Apr 01; 11(4):448-57. PubMed ID: 14713959
    [Abstract] [Full Text] [Related]

  • 18. Enhanced antitumor efficacy of a novel oncolytic adenovirus combined with temozolomide in the treatment of melanoma in vivo.
    Jiang G, Sun C, Li RH, Wei ZP, Zheng JN, Liu YQ.
    J Cancer Res Clin Oncol; 2015 Jan 01; 141(1):75-85. PubMed ID: 25103017
    [Abstract] [Full Text] [Related]

  • 19. YB-1 dependent virotherapy in combination with temozolomide as a multimodal therapy approach to eradicate malignant glioma.
    Holzmüller R, Mantwill K, Haczek C, Rognoni E, Anton M, Kasajima A, Weichert W, Treue D, Lage H, Schuster T, Schlegel J, Gänsbacher B, Holm PS.
    Int J Cancer; 2011 Sep 01; 129(5):1265-76. PubMed ID: 21710499
    [Abstract] [Full Text] [Related]

  • 20. Synergy of enediyne antibiotic lidamycin and temozolomide in suppressing glioma growth with potentiated apoptosis induction.
    Li XQ, Ouyang ZG, Zhang SH, Liu H, Shang Y, Li Y, Zhen YS.
    J Neurooncol; 2014 Aug 01; 119(1):91-100. PubMed ID: 24842385
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.